Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysis

Diabetes Obes Metab. 2022 Feb;24(2):337-342. doi: 10.1111/dom.14565. Epub 2021 Oct 27.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Biomarkers
  • Diabetes Mellitus, Type 2* / complications
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Biomarkers
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents